Influenza Vaccine Market Report

Global Influenza Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：169
  • REPORT CODE：GMM832851
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Influenza Vaccine market report explains the definition, types, applications, major countries, and major players of the Influenza Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • FluGen

    • BionVax

    • SK Chemicals

    • Novavax

    • Vaccitec

    • Altimmune

    • GlaxoSmithKline

    • Folia Biotech

    • Moderna Therapeutics

    • Green Cross

    • AstraZeneca

    • Shijiazhuang Yiling Pharmaceutical

    • Sanofi

    • Genentech

    • CSL

    • UNM Pharma

    • Medicago

    By Type:

    • Fluzone/Vaxigrip

    • FluMist

    • Fluarix and Flulaval

    • Anflu

    • Fluvax/Afluria

    • Flucelvax and Fluvirin

    By End-User:

    • Adults

    • Pediatrics

    • Senior Citizens

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Influenza Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Influenza Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Influenza Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Influenza Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Influenza Vaccine Market- Recent Developments

    • 6.1 Influenza Vaccine Market News and Developments

    • 6.2 Influenza Vaccine Market Deals Landscape

    7 Influenza Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Influenza Vaccine Key Raw Materials

    • 7.2 Influenza Vaccine Price Trend of Key Raw Materials

    • 7.3 Influenza Vaccine Key Suppliers of Raw Materials

    • 7.4 Influenza Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Influenza Vaccine Cost Structure Analysis

      • 7.5.1 Influenza Vaccine Raw Materials Analysis

      • 7.5.2 Influenza Vaccine Labor Cost Analysis

      • 7.5.3 Influenza Vaccine Manufacturing Expenses Analysis

    8 Global Influenza Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Influenza Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Influenza Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Influenza Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Influenza Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Fluzone/Vaxigrip Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global FluMist Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Fluarix and Flulaval Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Anflu Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Fluvax/Afluria Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Flucelvax and Fluvirin Consumption and Growth Rate (2017-2022)

    • 9.2 Global Influenza Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adults Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pediatrics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Senior Citizens Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Influenza Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Influenza Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Influenza Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Influenza Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Influenza Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Influenza Vaccine Consumption (2017-2022)

      • 10.3.2 UK Influenza Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Influenza Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Influenza Vaccine Consumption (2017-2022)

      • 10.3.5 France Influenza Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Influenza Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Influenza Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Influenza Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Influenza Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Influenza Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Influenza Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Influenza Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Influenza Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Influenza Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Influenza Vaccine Consumption (2017-2022)

      • 10.4.3 India Influenza Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Influenza Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Influenza Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Influenza Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Influenza Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Influenza Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Influenza Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Influenza Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Influenza Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Influenza Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Influenza Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Influenza Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Influenza Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Influenza Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Influenza Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Influenza Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Influenza Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Influenza Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Influenza Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Influenza Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Influenza Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Influenza Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Influenza Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Influenza Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Influenza Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Influenza Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Influenza Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Influenza Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Influenza Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Influenza Vaccine Consumption (2017-2022)

    11 Global Influenza Vaccine Competitive Analysis

    • 11.1 FluGen

      • 11.1.1 FluGen Company Details

      • 11.1.2 FluGen Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 FluGen Influenza Vaccine Main Business and Markets Served

      • 11.1.4 FluGen Influenza Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 BionVax

      • 11.2.1 BionVax Company Details

      • 11.2.2 BionVax Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 BionVax Influenza Vaccine Main Business and Markets Served

      • 11.2.4 BionVax Influenza Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 SK Chemicals

      • 11.3.1 SK Chemicals Company Details

      • 11.3.2 SK Chemicals Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 SK Chemicals Influenza Vaccine Main Business and Markets Served

      • 11.3.4 SK Chemicals Influenza Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Novavax

      • 11.4.1 Novavax Company Details

      • 11.4.2 Novavax Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Novavax Influenza Vaccine Main Business and Markets Served

      • 11.4.4 Novavax Influenza Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Vaccitec

      • 11.5.1 Vaccitec Company Details

      • 11.5.2 Vaccitec Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Vaccitec Influenza Vaccine Main Business and Markets Served

      • 11.5.4 Vaccitec Influenza Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Altimmune

      • 11.6.1 Altimmune Company Details

      • 11.6.2 Altimmune Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Altimmune Influenza Vaccine Main Business and Markets Served

      • 11.6.4 Altimmune Influenza Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 GlaxoSmithKline

      • 11.7.1 GlaxoSmithKline Company Details

      • 11.7.2 GlaxoSmithKline Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 GlaxoSmithKline Influenza Vaccine Main Business and Markets Served

      • 11.7.4 GlaxoSmithKline Influenza Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Folia Biotech

      • 11.8.1 Folia Biotech Company Details

      • 11.8.2 Folia Biotech Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Folia Biotech Influenza Vaccine Main Business and Markets Served

      • 11.8.4 Folia Biotech Influenza Vaccine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Moderna Therapeutics

      • 11.9.1 Moderna Therapeutics Company Details

      • 11.9.2 Moderna Therapeutics Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Moderna Therapeutics Influenza Vaccine Main Business and Markets Served

      • 11.9.4 Moderna Therapeutics Influenza Vaccine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Green Cross

      • 11.10.1 Green Cross Company Details

      • 11.10.2 Green Cross Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Green Cross Influenza Vaccine Main Business and Markets Served

      • 11.10.4 Green Cross Influenza Vaccine Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 AstraZeneca

      • 11.11.1 AstraZeneca Company Details

      • 11.11.2 AstraZeneca Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 AstraZeneca Influenza Vaccine Main Business and Markets Served

      • 11.11.4 AstraZeneca Influenza Vaccine Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Shijiazhuang Yiling Pharmaceutical

      • 11.12.1 Shijiazhuang Yiling Pharmaceutical Company Details

      • 11.12.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Main Business and Markets Served

      • 11.12.4 Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Sanofi

      • 11.13.1 Sanofi Company Details

      • 11.13.2 Sanofi Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Sanofi Influenza Vaccine Main Business and Markets Served

      • 11.13.4 Sanofi Influenza Vaccine Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Genentech

      • 11.14.1 Genentech Company Details

      • 11.14.2 Genentech Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Genentech Influenza Vaccine Main Business and Markets Served

      • 11.14.4 Genentech Influenza Vaccine Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 CSL

      • 11.15.1 CSL Company Details

      • 11.15.2 CSL Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 CSL Influenza Vaccine Main Business and Markets Served

      • 11.15.4 CSL Influenza Vaccine Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 UNM Pharma

      • 11.16.1 UNM Pharma Company Details

      • 11.16.2 UNM Pharma Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 UNM Pharma Influenza Vaccine Main Business and Markets Served

      • 11.16.4 UNM Pharma Influenza Vaccine Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Medicago

      • 11.17.1 Medicago Company Details

      • 11.17.2 Medicago Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Medicago Influenza Vaccine Main Business and Markets Served

      • 11.17.4 Medicago Influenza Vaccine Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    12 Global Influenza Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Influenza Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Fluzone/Vaxigrip Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global FluMist Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Fluarix and Flulaval Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Anflu Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Fluvax/Afluria Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Flucelvax and Fluvirin Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Influenza Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Senior Citizens Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Influenza Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Influenza Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Influenza Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Influenza Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Influenza Vaccine

    • Figure of Influenza Vaccine Picture

    • Table Global Influenza Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Influenza Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Fluzone/Vaxigrip Consumption and Growth Rate (2017-2022)

    • Figure Global FluMist Consumption and Growth Rate (2017-2022)

    • Figure Global Fluarix and Flulaval Consumption and Growth Rate (2017-2022)

    • Figure Global Anflu Consumption and Growth Rate (2017-2022)

    • Figure Global Fluvax/Afluria Consumption and Growth Rate (2017-2022)

    • Figure Global Flucelvax and Fluvirin Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatrics Consumption and Growth Rate (2017-2022)

    • Figure Global Senior Citizens Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Vaccine Consumption by Country (2017-2022)

    • Table North America Influenza Vaccine Consumption by Country (2017-2022)

    • Figure United States Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Influenza Vaccine Consumption by Country (2017-2022)

    • Figure Germany Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Influenza Vaccine Consumption by Country (2017-2022)

    • Figure China Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Influenza Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Influenza Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Influenza Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Influenza Vaccine Consumption by Country (2017-2022)

    • Figure Australia Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Influenza Vaccine Consumption and Growth Rate (2017-2022)

    • Table FluGen Company Details

    • Table FluGen Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table FluGen Influenza Vaccine Main Business and Markets Served

    • Table FluGen Influenza Vaccine Product Portfolio

    • Table BionVax Company Details

    • Table BionVax Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table BionVax Influenza Vaccine Main Business and Markets Served

    • Table BionVax Influenza Vaccine Product Portfolio

    • Table SK Chemicals Company Details

    • Table SK Chemicals Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table SK Chemicals Influenza Vaccine Main Business and Markets Served

    • Table SK Chemicals Influenza Vaccine Product Portfolio

    • Table Novavax Company Details

    • Table Novavax Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novavax Influenza Vaccine Main Business and Markets Served

    • Table Novavax Influenza Vaccine Product Portfolio

    • Table Vaccitec Company Details

    • Table Vaccitec Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vaccitec Influenza Vaccine Main Business and Markets Served

    • Table Vaccitec Influenza Vaccine Product Portfolio

    • Table Altimmune Company Details

    • Table Altimmune Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Altimmune Influenza Vaccine Main Business and Markets Served

    • Table Altimmune Influenza Vaccine Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Influenza Vaccine Main Business and Markets Served

    • Table GlaxoSmithKline Influenza Vaccine Product Portfolio

    • Table Folia Biotech Company Details

    • Table Folia Biotech Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Folia Biotech Influenza Vaccine Main Business and Markets Served

    • Table Folia Biotech Influenza Vaccine Product Portfolio

    • Table Moderna Therapeutics Company Details

    • Table Moderna Therapeutics Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Moderna Therapeutics Influenza Vaccine Main Business and Markets Served

    • Table Moderna Therapeutics Influenza Vaccine Product Portfolio

    • Table Green Cross Company Details

    • Table Green Cross Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Green Cross Influenza Vaccine Main Business and Markets Served

    • Table Green Cross Influenza Vaccine Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Influenza Vaccine Main Business and Markets Served

    • Table AstraZeneca Influenza Vaccine Product Portfolio

    • Table Shijiazhuang Yiling Pharmaceutical Company Details

    • Table Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Main Business and Markets Served

    • Table Shijiazhuang Yiling Pharmaceutical Influenza Vaccine Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Influenza Vaccine Main Business and Markets Served

    • Table Sanofi Influenza Vaccine Product Portfolio

    • Table Genentech Company Details

    • Table Genentech Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Influenza Vaccine Main Business and Markets Served

    • Table Genentech Influenza Vaccine Product Portfolio

    • Table CSL Company Details

    • Table CSL Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Influenza Vaccine Main Business and Markets Served

    • Table CSL Influenza Vaccine Product Portfolio

    • Table UNM Pharma Company Details

    • Table UNM Pharma Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table UNM Pharma Influenza Vaccine Main Business and Markets Served

    • Table UNM Pharma Influenza Vaccine Product Portfolio

    • Table Medicago Company Details

    • Table Medicago Influenza Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medicago Influenza Vaccine Main Business and Markets Served

    • Table Medicago Influenza Vaccine Product Portfolio

    • Figure Global Fluzone/Vaxigrip Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global FluMist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fluarix and Flulaval Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anflu Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fluvax/Afluria Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Flucelvax and Fluvirin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Senior Citizens Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Influenza Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Influenza Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US